UNH
UnitedHealth Group IncorporatedPrice history
Chart: TradingView’s own feed · page prices: 1D EODSnapshot
SEC EDGAR · FY 2025-12-31Revenue & Earnings — fiscal year
Financials — annual
SEC EDGAR · last 5 FY · tap a row to explain it| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $287.6B | $324.2B | $371.6B | $400.3B | $447.6B |
| Gross Profit | — | — | — | — | — |
| Operating Income | $24.0B | $28.4B | $32.4B | $32.3B | $19.0B |
| Net Income | $17.3B | $20.1B | $22.4B | $14.4B | $12.1B |
| Diluted EPS | $18.08 | $21.18 | $23.86 | $15.51 | $13.23 |
| Operating Cash Flow | $22.3B | $26.2B | $29.1B | $24.2B | $19.7B |
| Free Cash Flow | $19.9B | $23.4B | $25.7B | $20.7B | $16.1B |
Deep dive
Computed from the SEC EDGAR multi-year statementsOperating leverage — margins
FY25 cash-flow waterfall
UNH story timeline
Company updates and connected market context, with the dated price move attached.
CVS Still Sees 'High-Trend' Cost Growth; Oscar, UNH Stock Fall
CVS said medical-cost growth remains at a high trend, sending Oscar and UnitedHealth shares lower. The read-through keeps utilization and margin pressure at the center of the managed-care setup, with no company-specific offset established in the report.
Health insurers are dumping Medicare Advantage plans. Here’s how many seniors could be affected.
Health insurers are withdrawing Medicare Advantage plans, potentially forcing seniors—especially in rural areas with fewer alternatives—to find new coverage next year. The retrenchment highlights regulatory and utilization-cost pressure across UNH, HUM and CVS.
Related Stocks
Click to exploreFundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.